GLP-1 Weight-Loss Drugs Outpace Europe’s Health Systems, Obesity Experts Warn
A new EASO position statement argues that Europe's health systems must be restructured around five pillars to deliver the benefits ...
Tag: incretin-based therapies
Glucose-Lowering Drugs and Brain Health: Mechanisms, Evidence, and Future Directions
Scientists are taking a hard look at whether the world's most widely prescribed diabetes medications could do far more than ...
ADLM 2026 to Highlight Diabetes Milestones, Space Diagnostics, and Cancer Biomarkers
ANAHEIM, CALIF. — From July 26–30, the brightest minds in clinical laboratory medicine will gather in Anaheim for ADLM 2026, ...
Obesity and Dietitian Groups Release Guidelines on Incretin Drug Use
Obesity treatment has entered a transformative era with the rise of incretin-based therapies (IBTs), notably GLP-1 receptor agonists, which have ...
Incretin-Based Therapies Combat Neurodegenerative Diseases
Neurodegenerative disorders have long posed one of the most daunting challenges in modern medicine. These diseases, marked by relentless neuronal ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!